[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"sstr-positive-tumors\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:sstr-positive-tumors":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,52],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":32,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":41,"startDateStruct":44,"completionDateStruct":46,"leadSponsor":48,"locationsCount":51},"100370529","clinico-biological-database-in-patients-treated-with-metabolic-radiotherapy-in-the-nuclear-medicine-department-100370529",false,"NCT04104529","Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department","Establishment of a Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department","BCB RIV","Inclusion Criteria:\n\n* Age ≥ at 18 years old,\n* Patient treated in the Nuclear Medicine Department for the treatment by metabolic radiotherapy,\n* Patient treated as part of his treatment for:\n\n  * thyroid cancer,\n  * a neuroendocrine tumor or any SSTR positive tumours (like meningiomas) receiving PRRT\n  * prostate cancer.\n* Patient having accepted the complementary blood sample,\n* Patient having given his informed, written and express consent.\n\nExclusion Criteria:\n\n* Patient not affiliated to a social security scheme,\n* Subject under tutelage, curatorship or safeguard of justice,\n* Patient in an emergency situation\n* Patient whose regular monitoring is a priori impossible for psychological, family, social or geographical reasons,\n* Pregnant and \u002F or breastfeeding woman","ALL","18 Years",{"count":20,"type":21},350,"ESTIMATED","INTERVENTIONAL",[24],"NA","Development of a clinico-biological database allowing the provision of clinical data and corresponding biological materials to the medical and scientific community.",[27,28,29,30,31],"Thyroid Cancer","Prostate Cancer","Neuroendocrine Tumors","SSTR Positive Tumors","Meningioma",[33,34,35,36,37,38],"thyroid cancer","prostate cancer","neuroendocrine tumors","nuclear medecine","SSTR positive tumors","meningiomas","RECRUITING","2026-09-11",{"date":42,"type":43},"2026-09-15","ACTUAL",{"date":45,"type":43},"2019-10-28",{"date":47,"type":21},"2029-10",{"name":49,"class":50},"Institut du Cancer de Montpellier - Val d'Aurelle","OTHER",4,{"id":53,"slug":54,"hasResults":11,"nctId":55,"briefTitle":56,"officialTitle":56,"acronym":4,"eligibilityCriteria":57,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":58,"targetDuration":4,"studyType":22,"phases":60,"briefSummary":63,"conditions":64,"keywords":4,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":74},"100496826","phase-2-application-of-al18f-octreotide-petct-in-tumors-with-positive-sstr-expression-100496826","NCT05749289","Application of Al18F-octreotide PET\u002FCT in Tumors With Positive SSTR Expression","Inclusion Criteria:\n\n* Patients with suspected or clearly diagnosed SSTR positive tumors\n* signed written consent.\n* Willing and able to cooperate with all projects in this study.\n\nExclusion Criteria:\n\n* pregnancy;\n* breastfeeding;\n* any medical condition that in the opinion of the investigator may significantly interfere with study compliance.",{"count":59,"type":21},400,[61,62],"PHASE2","PHASE3","This is an open-label whole-body PET\u002FCT study for investigating the value of Al18F-octreotide PET\u002FCT in patients with SSTR positive tumors",[30],"2026-03-31",{"date":67,"type":43},"2026-04-06",{"date":69,"type":43},"2022-12-20",{"date":71,"type":21},"2029-12-20",{"name":73,"class":50},"Cancer Institute and Hospital, Chinese Academy of Medical Sciences",1]